Ischemia-reperfusion injury stimulates gelatinase expression and activity in kidney glomeruli

Canadian Journal of Physiology and Pharmacology

Volumn 83, Issue 3, 2005, Pages 287-300

  Caron, Annick ^a   Desrosiers, Richard R ^a   Langlois, Stéphanie ^a   Béliveau, Richard ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

CD 44; Gelatinases; Glomeruli; Ischemia reperfusion; LRP; TIMPs; ZO 1

Indexed keywords

GELATIN; GELATINASE; GELATINASE A; HERMES ANTIGEN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CLAMP; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; GLOMERULUS; IN VIVO STUDY; KIDNEY FAILURE; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTIGENS, CD44; ANTIGENS, CD45; CREATININE; GENE EXPRESSION REGULATION; HUMANS; KIDNEY GLOMERULUS; LDL-RECEPTOR RELATED PROTEIN 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; MICE; RABBITS; RATS; REPERFUSION INJURY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 21744453476     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y05-011     Document Type: Article

References (60)

1. Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M.A. et al. 2001. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21: 7724-7732.
2. Azuma, H., Nadeau, K., Takada, M., MacKenzie, H.S., and Tilney, N.L. 1997. Cellular and molecular predictors of chronic renal dysfunction after initial ischemia/reperfusion injury of a single kidney. Tranplantation, 64: 190-197.
3. Basile, D.P., Martin, D.R., and Hammerman, M.R. 1998. Extracellular matrix-related genes in kidney after ischemic injury: potential role for TGF-beta in repair. Am. J. Physiol. 275: F894-F903.
4. Booth, A.G., and Kenny, A.J. 1974. A rapid method for preparation of microvilli from rabbit kidney. Biochem. J. 142: 575-581.
5. Brew, K., Dinakarpandian, D., and Nagase, H. 2000. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta, 1477: 267-283.
6. 1 cells. Am. J. Physiol. 261: F1038-F1045.
7. Caron, A., Desrosiers, R.R., and Beliveau, R. 2004. Kidney ischemia-reperfusion regulates expression and distribution of tubulin subunits, beta-actin and rho GTPases in proximal tubules. Arch. Biochem. Biophys. 431: 31-46.
8. Cawston, T. 1998. Matrix metalloproteinases and TIMPs: properties and implications for rheumatic diseases. Mol. Med. Today 272: 33175-33180.
9. Cheung, P.Y., Sawicki, G., Wozniak, M., Wang, W., Radomski, N.W., and Schulz, R. 2000. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation, 101: 1833-1839.
10. Desrosiers, R.R., Gauthier, F., Lanthier, J., and Béliveau, R. 2000. Modulation of Rho and cytoskeletal protein attachment to membranes by prenylcysteine analog. J. Biol. Chem. 275: 14949-14957.
11. Deten, A., Holzl, A., Leicht, M., Barth, W., and Zimmer, H.G. 2001. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J. Mol. Cell. Cardiol. 33: 1191-1207.
12. Essig, M., Vrtovsnik, F., Nguyen, G., Sraer, J.D., and Friedlander, G. 1998. Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins. J. Am. Soc. Nephrol. 9: 1377-1388.
13. Forbes, J.M., Hewitson, T.D., Becker, G.J., and Jones, C.L. 2000. Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney. Int. 57: 2375-2385.
14. Forget, M.-A., Desrosiers, R.R., and Béliveau, R. 1999. Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis. Can. J. Physiol. Pharmacol. 77: 1-16.
15. Forpomès, O., Combe, C., Camber, J., and Aparicio, M. 1997. Cyclosporin-A- and angiotensin-II-induced vasoreactivity in isolated glomeruli and cultured mesangial cells, 4 and 24 h after renal mass reduction: role of vasodilatory prostaglandins. Nephron, 76: 337-344.
16. Granelli-Piperno, A., and Reich, E. 1978. A study of proteases and protease inhibitor complexes in biological fluids. J. Exp. Med. 148: 223-234.
17. Hahn-Dantona, E., Ruiz, J.F., Bornsteinm, P., and Strickland, D.K. 2001. The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism. J. Biol. Chem. 276: 15498-15503.
18. Hall, J.E., Brands, M.W., and Henegar, J.R. 1999. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J. Am. Soc. Nephrol. 10: S258-S265.
19. Harkness, K.A., Adamson, P., Sussman, J.D., Davies-Jones, G.A., Greenwood, J., and Woodroofe, M.N. 2000. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain, 123: 698-709.
20. Hojo, Y., Ikeda, U., Ueno, S., Arakawa, H., and Shimada, K. 2001. Expression of matrix metalloproteinases in patients with acute myocardial infarction. Jpn. Circ. J. 65: 71-75.
21. Irie-Sasaki, J., Sasaki, T., and Penninger, J.M. 2003. CD45 regulated signaling pathways. Curr. Top. Med. Chem. 3: 783-796.
22. Jiang, Y., Goldberg, I.D., and Shi, YE. 2002. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene, 21: 2245-2252.
23. Kelly, M.H., and Hamilton, J.R. 1970. A micro-technique for the assay of intestinal alkaline phosphatase. Results in normal children and in children with celiac disease. Clin. Biochem. 3: 33-43.
24. Klausner, J.M., Paterson, I.S., Goldman, G, Kobzik, L., Rodzen, C., Lawrence, R. et al. 1989. Postischemic renal injury is mediated by neutrophils and leukotrienes. Am. J. Physiol. 256: F794-F802.
25. Kroshian, V.M., Sheridan, A.M., and Lieberthal, W. 1994. Functional and cytoskeletal changes induced by sublethal injury in proximal tubular epithelial cells. Am. J. Physiol. 266: F21-F30.
26. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680-685.
27. Lambert, C.A., Colige, A.C., Munaut, C., Lapiere, C.M., and Nusgens, B.V. 2001. Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension. Matrix Biol. 20: 397-408.
28. Le, Q.C., Shah, S.V., Nguyen, H.H., Cortez, S.L., and Baricos, V.H. 1991. A novel metalloproteinase present in freshly isolated rat kidney. Am. J. Physiol. 260: F555-F561.
29. Lelongt, B., Bengatta, S., Delauche, M., Lund, L.R., Werb, Z., and Ronco, P.M. 2001. Matrix metalloproteinase 9 protects mice from anti-glomerular basement membrane nephritis through its fibrinolytic activity. J. Exp. Med. 193: 793-802.
30. Lewington, A.J.P., Padanilam, B.J., Martin, D.R., and Hammerman, M.R. 2000. Expression of CD-44 in kidney after acute ischemic injury in rats. Am. J. Physiol. 278: R247-R254.
31. Liano, F., and Pascual, J. 1996. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 50: 811-818.
32. Lijnen, H.R. 2002. Molecular interactions between the plasminogen/plasmin and matrix metalloproteinase systems. Fibrinolysis Proteolysis 14: 175-181.
33. Lu, L., Gunja-Smith, Z., Woessner, J.F., Ursell, P.C., Nissen, T., Galardy, R.E. et al. 2000. Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo. Am. J. Physiol. 279: H601-H609.
34. Makino, H., Sugiyama, H., and Kashihara, N. 2000. Apoptosis and extracellular matrix-cell interactions in kidney disease. Kidney Int. Suppl. 77: S67-S75.
35. Malek, A.M., and Izumo, S. 1996. Mechanism of endothelial cell shape change and cytoskeletal remodeling in response to fluid shear stress. J. Cell Sci. 109: 713-726.
36. Masure, S., Nys, G., Van Damme, J., and Opdenakker, G. 1993. Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEH1-3 macrophages and gene organization. Eur. J. Biochem. 218: 129-141.
37. McLennan, S.V., Kelly, D.J., Cox, A.J., Cao, Z., Lyons, J.G., Yue, D.K. et al. 2002. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia, 45: 268-275.
38. McMillan, J.L., Riordan, J.W., Couser, J.W., Pollock, A.S., and Lovett, D.H. 1996. Characterization of glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membrane nephropathy. J. Clin. Investig. 15: 1094-1101.
39. Murphy, G., and Willenbrock, F. 1995. Tissue inhibitors of matrix metalloendopeptidases. Methods. Enzymol. 248: 496-510.
40. Nguyen, H.H., Baricos, W.H., and Shah, S.V. 1986. Degradation of glomerular basement membrane by a neutral metalloproteinase present in glomeruli isolated from normal rat kidney. Biochem. Biophys. Res. Commun. 141: 898-903.
41. Noakes, P.G., Miner, J.H., Gautam, M., Gunningham, J.M., Sanes, J.R., and Merlie, J.P. 1995. The renal glomerulus of mice lacking s-laminin/laminin beta 2: nephrosis despite molecular compensation by laminin beta 1. Nat. Genet. 10: 400-406.
42. Olson, M.W., Bernardo, M.M., Pietila, M., Gervasi, D.C., Toth, M., Kotra, L.P. et al. 2000. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. J. Biol. Chem. 275: 2661-2668.
43. Pagtalunan, M.E., Olson, J.L., Tilney, N.L., and Meyer, T.W. 1999. Late consequences of acute ischemic injury to a solitary kidney. J. Am. Soc. Nephrol. 10: 366-373.
44. Pepper, M.S. 2001. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21: 1104-1117.
45. Planas, A.M., Sole, S., and Justicia, C. 2001. Expression and activation of matrix metalloproteinase-2 and -9 in rat brain after transient focal cerebral ischemia. Neurobiol. Dis. 8: 834-846.
46. Rosenberg, G.A., Cunningham, L.A., Wallace, J., Alexander, S., Estrada, E.Y., Grossetete, M. et al. 2001. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res. 893: 104-112.
47. Rudd, P.M., Mattu, T.S., Masure, S., Bratt, T., Van den Steen, P.E., Wormald, M. et al. 1999. The glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. Biochemistry, 38: 13937-13950.
48. Shimamori, Y., Waranabe, Y., and Fujimoto, Y. 1995. Characterization of gelatinases in human placenta. Biochem. Mol. Med. 56: 84-86.
49. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, FH., Provenzano, M.D. et al. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
50. Smoyer, W.E., Ransom, R., Harris, R.C., Welsh, M.J., Lutsch, G., and Benndorf, R. 2000. Ischemic acute renal failure induces differential expression of small heat shock proteins. J. Am. Soc. Nephrol. 11: 211-221.
51. Spessotto, P., Rossi, P.M., Degan, M., Di Francia, R., Perris, R., Colombatti, A. et al. 2002. Hyaluronan-CD-44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J. Cell Biol. 158: 1133-1144.
52. Stevenson, B.R., Silicano, J.D., Mooseker, M., and Goodenough, D.A. 1986. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J. Cell Biol. 103: 755-766.
53. Sumii, T., and Lo, E.H. 2002. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke, 33: 831-836.
54. Sutton, T.A., and Molitoris, B.A. 1998. Mechanisms of cellular injury in ischemic acute renal failure. Semin. Nephrol. 18: 490-497.
55. Upadhya, A.G., Harvey, R.P.C., Howard, T.K., Lowell, J.A., Shenoy, A., and Strasberg, S.M. 1997. Evidence of a role of matrix metalloproteinases in cold preservation injury of the liver in humans and in the rat. Hepatology, 26: 922-928.
56. Valdivielso, J.M. Crespo, C., Alonso, J.R., Martinez-Salgado, C., Eleno, N., Arévalo, M. et al. 2001. Renal ischemia in the rat stimulates glomerular nitric oxide synthesis. Am. J. Physiol. Reg. Int. Comp. Physiol. 280: R771-R779.
57. Wang, W., Sawicki, G., and Schulz, R. 2002. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc. Res. 53: 165-174.
58. Woessner, J.F., Jr. 1998. The matrix metalloproteinases family. Matrix metalloproteinases. Academic Press. pp. 1-13.
59. Ziswiler, R., Daniel, C., Franz, E., and Marti, H.-P. 2001. Renal matrix metalloproteinase activity is unaffected by experimental ischemia-reperfusion injury and matrix metalloproteinase inhibition does not alter outcome of renal function. Exp, Nephrol. 9: 118-124.
60. Zuk, A., Bonventre, J.V., Brown, D., and Matlin, K.S. 1998. Polarity, integrin and extracellular matrix dynamics in the postischemic rat kidney. Am. J. Physiol. 275: C711-C731.